ASAS, BASDAI AND ASDAS REMISSION IN SECUKINUMAB TREATED PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 3-YEAR RESULTS FROM A POOLED ANALYSIS OF TWO PHASE 3 STUDIES

被引：0
|
作者：
Baraliakos, X. [1 ]
Van den Bosch, F. [2 ,3 ]
Machado, P. [4 ]
Gensler, L. [5 ]
Bintu, S. [6 ]
Porter, B. [7 ]
Gaillez, C. [8 ]
Deodhar, A. [9 ]
机构：
[1] Ruhr Univ Bochum, Bochum, Germany
[2] Univ Ghent, Ghent, Belgium
[3] Ghent Univ Hosp, Ghent, Belgium
[4] UCL, London, England
[5] UCSF Sch Med, San Francisco, CA USA
[6] RTI Hlth Solut, Res Triangle Pk, NC USA
[7] Novartis Pharmaceut, E Hanover, NJ USA
[8] Novartis Pharma AG, Basel, Switzerland
[9] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P129
引用
收藏
页码：743 / 743
页数：1
相关论文
共 50 条
  • [1] Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies
    Baraliakos, Xenofon
    Van den Bosch, Filip
    Machado, Pedro M.
    Gensler, Lianne S.
    Marzo-Ortega, Helena
    Sherif, Bintu
    Quebe-Fehling, Erhard
    Porter, Brian
    Gaillez, Corine
    Deodhar, Atul
    [J]. RHEUMATOLOGY AND THERAPY, 2021, 8 (01) : 273 - 288
  • [2] Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies
    Xenofon Baraliakos
    Filip Van den Bosch
    Pedro M. Machado
    Lianne S. Gensler
    Helena Marzo-Ortega
    Bintu Sherif
    Erhard Quebe-Fehling
    Brian Porter
    Corine Gaillez
    Atul Deodhar
    [J]. Rheumatology and Therapy, 2021, 8 : 273 - 288
  • [3] Reduction in fatigue in patients with active ankylosing spondylitis: results of two phase 3 studies of secukinumab
    Kvien, T. K.
    Conaghan, P.
    Deodhar, A.
    Gossec, L.
    Ostergaard, M.
    Canete, J.
    Gandhi, K.
    Richards, H.
    Williams, N.
    Jugl, S.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 : 35 - 36
  • [4] REDUCTION IN FATIGUE IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS OF TWO PHASE 3 STUDIES OF SECUKINUMAB
    Kvien, T. K.
    Conaghan, P. G.
    Deodhar, A.
    Gossec, L.
    Ostergaard, M.
    Canete, J.
    Gandhi, K.
    Richards, H.
    Williams, N.
    Jugl, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 823 - 823
  • [5] Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52-week pooled results from two phase 3 studies
    Wei, James C. -C.
    Baeten, Dominique
    Sieper, Joachim
    Deodhar, Atul
    Bhosekar, Vaishali
    Martin, Ruvie
    Porter, Brian
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (05) : 589 - 596
  • [6] Incidence of Uveitis in Secukinumab-treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies
    Deodhar, Atul A.
    Miceli-Richard, Corine
    Baraliakos, Xenofon
    Marzo-Ortega, Helena
    Gladman, Dafna D.
    Blanco, Ricardo
    Das Gupta, Ayan
    Martin, Ruvie
    Safi, Jorge
    Porter, Brian
    Shete, Abhijit
    Rosenbaum, James T.
    [J]. ACR OPEN RHEUMATOLOGY, 2020, 2 (05) : 294 - 299
  • [7] Performance of BASDAI Versus ASDAS in Evaluating Axial Involvement in Patients With PsA Treated With Guselkumab: Pooled Analysis of Two Phase 3 Studies
    Baraliakos, Xenofon
    Gladman, Dafna
    Chakravarty, Soumya
    Gong, Cinty
    Shawi, May
    Rampakakis, Emmanouil
    Kishimoto, Mitsumasa
    Soriano, Enrique
    Mease, Philip
    [J]. JOURNAL OF RHEUMATOLOGY, 2023, 50 (07) : 31 - 31
  • [8] Safety and Tolerability of Secukinumab in Patients with Active Ankylosing Spondylitis: Pooled Safety Analysis of Two Phase 3, Randomized, Controlled Trials
    Deodhar, Atul A.
    Baeten, Dominique
    Sieper, Joachim
    Porter, Brian
    Widmer, Albert
    Richards, Hanno
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [9] Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis: Pooled Safety Analysis of Two Phase 3, Randomized, Controlled Trials
    Kyburz, D.
    Deodhar, A.
    Baeten, D.
    Sieper, J.
    Porter, B.
    Widmer, A.
    Richards, H.
    [J]. SWISS MEDICAL WEEKLY, 2016, 146 : 6S - 6S
  • [10] High Retention Rate and Sustained Responses with Secukinumab 150mg in Patients with Active Ankylosing Spondylitis: 3-Year Results from a Phase 3 Study
    Kivitz, Alan J.
    Marzo-Ortega, Helena
    Legerton, Clarence
    Sieper, Joachim
    Blanco, Ricardo
    Cohen, Martin
    Delicha, Evie Maria
    Rohrer, Susanne
    Richards, Hanno
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345